Baby Isn’t Theirs—Where’s Their Embryo?

A Florida IVF clinic mix-up allegedly left one family raising a baby that isn’t genetically theirs—exposing how lightly regulated, high-stakes fertility medicine can upend lives overnight.

Quick Take

DNA testing has identified the baby’s genetic parents, referred to in court filings as “Patient Four,” after a court-ordered testing effort.
The birth parents, Tiffany Score and Steven Mills, say they noticed a racial mismatch at birth and later confirmed through genetic testing that the child is not biologically related to them.
The lawsuit targets The Fertility Center of Orlando (IVF Life), as the couple says the clinic initially failed to respond and they still don’t know what happened to their own embryos.
The case highlights a major policy gap: the U.S. has no single federal IVF regulatory framework, leaving oversight to states and accreditation systems.

How the mix-up came to light—and why it moved so fast

Tiffany Score and Steven Mills pursued IVF through The Fertility Center of Orlando, with an embryo transfer in April 2025 and a delivery on December 24, 2025. The couple says they immediately noticed the newborn appeared non-Caucasian, raising concerns that something went wrong in the lab. Genetic testing later confirmed the baby—named Shea—is not biologically related to either parent, prompting a lawsuit and an urgent push to identify the child’s genetic family.

The visible mismatch is a major reason this case escalated quickly. Many fertility errors are discovered later, after medical questions arise or consumer DNA tests reveal surprises years down the road. Here, the couple says the discrepancy was apparent at birth, and a DNA test reportedly returned a near-certain non-match. That immediate clarity accelerated legal action, but it also created a painful reality: bonding and parenthood began long before the biology was understood.

What “Patient Four” means: identification without public exposure

Recent reporting indicates the baby’s genetic parents have now been identified through testing, described in legal materials as “Patient Four.” Their identities remain confidential, and the couple’s attorney, Jack Scarola, has said privacy will be respected as the families communicate. The couple has also signaled conflicting, human impulses: deep attachment to the child they carried and raised, and a stated moral obligation to notify the biological parents who may have been unknowingly separated from their child.

This identification step closes only one part of the story. The legal conflict is not simply about who the genetic parents are, but about how the error occurred and what remedies exist for all parties. Reports indicate a judge ordered testing for people connected to an April 2025 transfer window and for patients tied to a March 2020 egg retrieval cohort, suggesting investigators are tracing possible mislabeling or storage mistakes across multiple years. So far, only one match has been reported.

The unanswered question conservatives keep coming back to: where is the oversight?

The case is drawing attention because IVF combines life-and-death seriousness with a patchwork oversight model. The reporting and court activity described in this dispute underscore that many safeguards depend on clinic protocols, lab procedures, and after-the-fact litigation. When something goes wrong, families often rely on judges and attorneys to force records disclosure, testing, and accountability—tools that arrive only after harm occurs. That dynamic is fueling calls for clearer standards and enforceable safeguards.

Accountability, custody, and the cost of a “systems failure”

For the couple, the stakes include emotional trauma, legal bills, and the unresolved status of their own embryos—an issue that goes beyond money and into basic rights over family creation. For the genetic parents, the stakes include lost time with their biological child and uncertainty about what comes next. For the clinic, the stakes include liability and public trust. Without a clear resolution framework, the case risks turning a child’s future into a prolonged contest shaped by court calendars.

Florida couple in alleged embryo mix-up have identified biological parents of 'non-caucasian' baby https://t.co/1Jdijulx7D pic.twitter.com/Cjjr8T45v0

— New York Post (@nypost) April 23, 2026

Politically, the controversy lands in the middle of broader frustration about institutions that feel unaccountable—from federal agencies to large medical systems. Conservatives often argue that markets and innovation work best when paired with transparent rules and consequences for negligence. Liberals often argue that private healthcare needs stricter regulation. This case is one of the rare flashpoints where both instincts can overlap: when errors involve human embryos and newborns, “buyer beware” is not an acceptable standard.